Literature DB >> 8797010

Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.

G Li1, J M Silverman, L D Altstiel, V Haroutunian, D P Perl, D Purohit, S Birstein, M Lantz, R C Mohs, K L Davis.   

Abstract

Recent studies have found an association between presence of apolipoprotein E (APOE) epsilon 4 allele and Alzheimer's disease (AD). The present study compared the cumulative risk of primary progressive dementia (PPD) in relatives of AD probands carrying at least one copy of the epsilon 4 allele with the relatives of AD probands not carrying epsilon 4 and with relatives of non-demented controls. Our aim was to determine whether the familial aggregation of PPD in relatives of AD probands is primarily due to those carrying epsilon 4. Seventy-seven neuropathologically diagnosed AD patients were obtained as probands through our Alzheimer's Disease Research Center Brain Bank. AD probands were genotyped for APOE. As a comparison group, 198 non-demented probands were also included. Through family informants, demographic and diagnostic data were collected on 382 first-degree relatives (age > or = 45 years) of AD probands and 848 relatives of the controls. We found that the cumulative risk of PPD in both relatives of AD probands with and without the epsilon 4 allele was significantly higher than that in the relatives of non-demented controls. However, the increased risk in the relatives of AD probands with the epsilon 4 allele was marginally, but not significantly, lower than the risk in the relatives of probands without epsilon 4. A greater likelihood of death by heart diseases over developing PPD in relatives of AD probands with epsilon 4 (3.1-fold increase) was found compared to relatives of probands without epsilon 4 (1.7-fold increase), especially prior to age 70, although the difference was not statistically significant. The increased familial risk for PPD in the relatives of AD probands with the APOE-epsilon 4 allele relative to controls suggests that familial factors in addition to APOE-epsilon 4 are risk factors for AD. Differential censorship from increased mortality of heart diseases may have prevented a higher incidence of PPD among the relatives of probands with epsilon 4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797010     DOI: 10.1002/(SICI)1098-2272(1996)13:3<285::AID-GEPI5>3.0.CO;2-5

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  6 in total

1.  Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Authors:  S Danet; T Brousseau; F Richard; P Amouyel; C Berr
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

Review 2.  Behavioral genetics '97: ASHG statement. Recent developments in human behavioral genetics: past accomplishments and future directions.

Authors:  S L Sherman; J C DeFries; I I Gottesman; J C Loehlin; J M Meyer; M Z Pelias; J Rice; I Waldman
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

3.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Increased longevity in offspring of mothers with Alzheimer's disease.

Authors:  Jeremy M Silverman; James Schmeidler; Michal Schnaider-Beeri; Hillel T Grossman; Xiaodong Luo; Rebecca West; Rachel C Lally; Joy Y Wang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

Review 5.  Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Tingting Xiao; Bin Jiao; Weiwei Zhang; Beisha Tang; Lu Shen
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

6.  Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.

Authors:  Jill S Goldman; Susan E Hahn; Jennifer Williamson Catania; Susan LaRusse-Eckert; Melissa Barber Butson; Malia Rumbaugh; Michelle N Strecker; J Scott Roberts; Wylie Burke; Richard Mayeux; Thomas Bird
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.